S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
NYSE:OGEN

Oragenics (OGEN) Stock Price, News & Analysis

$1.40
-0.01 (-0.71%)
(As of 03/27/2024 ET)
Today's Range
$1.38
$1.45
50-Day Range
$1.38
$6.14
52-Week Range
$1.26
$7.74
Volume
36,278 shs
Average Volume
88,558 shs
Market Capitalization
$6.27 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Oragenics

Oragenics, Inc., a development-stage company, engages in the research and development of antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus. The company's product candidates also comprise LPT3-04, a weight loss candidate; and SMaRT Replacement Therapy, a topical treatment to prevent dental carries. It has a license agreement with Noachis Terra Inc. for licensing of certain specified patent rights and biological materials relating to the use of pre-fusion coronavirus spike proteins; and a collaboration agreement ILH Holdings, Inc. for the development and commercialization of MU1140 and related homologs. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Tampa, Florida.

OGEN Stock Price History

OGEN Stock News Headlines

Oragenics Appoints Kelly As Chief Medical Officer
[BUY ALERT] Our #1 A.I. Stock for March
It's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.
15 Highest Quality Probiotics For Gut Health
Oragenics Announces Closing of Public Offering
Oragenics announces public stock offering
Why Is Oragenics (OGEN) Stock Down 45% Today?
[BUY ALERT] Our #1 A.I. Stock for March
It's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.
Oragenics Announces Pricing of Public Offering
Oragenics Shares Fall After Proposed Public Offering
Oragenics Announces Proposed Public Offering
Oragenics, Inc. Announces Leadership Transition
OGEN, RLMD and ATXI among mid-day movers
Oragenics, Inc. (UAV.F)
Oragenics Issues Update to Shareholders
See More Headlines
Receive OGEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oragenics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/16/2021
Today
3/27/2024
Next Earnings (Estimated)
4/12/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Employees
6
Year Founded
N/A

Profitability

Net Income
$-14,290,000.00
Pretax Margin
-26,700.00%

Debt

Sales & Book Value

Annual Sales
$130,000.00
Book Value
$5.64 per share

Miscellaneous

Free Float
3,379,000
Market Cap
$6.27 million
Optionable
N/A
Beta
0.29
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Charles L. Pope CPA (Age 72)
    Executive Chairman
    Comp: $82.5k
  • Mr. Joseph Michael Redmond (Age 63)
    President & Interim Principal Executive Officer
  • Ms. Janet Huffman (Age 52)
    CFO, Secretary & Treasurer
  • Dr. James P. Kelly M.A.
    M.D., Chief Medical Officer & Member of Scientific Advisor

OGEN Stock Analysis - Frequently Asked Questions

How have OGEN shares performed in 2024?

Oragenics' stock was trading at $6.1382 on January 1st, 2024. Since then, OGEN stock has decreased by 77.2% and is now trading at $1.40.
View the best growth stocks for 2024 here
.

When is Oragenics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, April 12th 2024.
View our OGEN earnings forecast
.

How were Oragenics' earnings last quarter?

Oragenics, Inc. (NYSE:OGEN) issued its quarterly earnings results on Monday, August, 16th. The company reported ($1.80) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($2.40) by $0.60.

When did Oragenics' stock split?

Shares of Oragenics reverse split before market open on Monday, January 23rd 2023. The 1-60 reverse split was announced on Monday, January 23rd 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, January 23rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

What other stocks do shareholders of Oragenics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Oragenics investors own include Yunji (YJ), MFA Financial (MFA) and

How do I buy shares of Oragenics?

Shares of OGEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:OGEN) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners